Optinose Announced That Xhance (Fluticasone Propionate) Has Been Added To Express Scripts' National Formularies, Including The National Preferred, Flex, And Basic Formularies
Portfolio Pulse from Benzinga Newsdesk
Optinose announced that its product Xhance (Fluticasone Propionate) has been added to Express Scripts' national formularies, including the National Preferred, Flex, and Basic Formularies.
June 27, 2024 | 11:11 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Optinose's Xhance has been added to Express Scripts' national formularies, which could increase the product's accessibility and sales.
Being added to Express Scripts' national formularies means increased accessibility for Xhance, which could lead to higher sales and revenue for Optinose. This is a positive development for the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100